Raffaele Di Taranto
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Why do bisphosphonates work in the treatment of CRPS? A translational pharmacological perspective to solve a conundrum.
Journal: Expert review of clinical pharmacology
Published: August 05, 2026
Effectiveness and safety of neridronate in chronic nonbacterial osteomyelitis: insight from the CAMELOT registry.
Journal: Therapeutic advances in musculoskeletal disease
Published: January 19, 2026
How postmenopausal osteoporosis influences epidemiology and clinical features of CRPS-1.
Journal: Journal of bone and mineral metabolism
Published: September 12, 2025
Safety of intravenous neridronate in pediatric patients: insights from the monocentric retrospective NAPOLEON cohort.
Journal: Therapeutic advances in musculoskeletal disease
Published: August 20, 2025
The assessment and management of bone health in pediatric-onset rheumatological diseases from early age to adulthood: A critical overview.
Journal: Autoimmunity reviews
Published: May 08, 2025
Vertebral fractures and bone health in patients with chronic non-bacterial osteomyelitis at disease onset: insights from the monocentric CAMELOT cohort.
Journal: Therapeutic advances in musculoskeletal disease
Published: February 18, 2025
Osteoclast in CRPS: an alleged guilty fully acquitted.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: December 10, 2024
Bone Turnover Markers and Wnt Signaling Modulators in Early Complex Regional Pain Syndrome. A Pre-specified Observational Study.
Journal: Calcified tissue international
Published: April 23, 2024
Bone Involvement in Rheumatoid Arthritis and Spondyloartritis: An Updated Review.
Journal: Biology
Published: September 11, 2023
Effect of neridronate on axial involvement in patients with spondyloarthritis when biologics are not possible. Results of a monocentric study.
Journal: Frontiers in medicine
Published: August 23, 2023
The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events.
Journal: Frontiers in immunology
Published: May 18, 2023
How the COVID-19 pandemic affected bone health: a retrospective, longitudinal study on denosumab persistence from the epicentre of European spreading.
Journal: Archives of osteoporosis
Published: April 17, 2023
Last Updated: 09/26/2026